跳至主要内容
临床试验/ACTRN12616001385437
ACTRN12616001385437招募中1 期

Assessing feasibility, safety and efficacy of IVIg therapy in patients with acute traumatic spinal cord injury

niversity of Queensland0 个研究点目标入组 40 人开始时间: 2016年10月6日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • Acute traumatic cervical or thoracic spinal cord injury (up to T9).
  • Initiation of IVIg treatment must be within 12 hours of injury.

排除标准

  • 1.Known hypersensitivity to Privigen
  • 2.History of significant cardiovascular, liver or kidney disease
  • 3.Unconscious
  • 4.Penetrating spinal cord injury
  • 5.Involvement in another SCI research project
  • 6.Presence of a mental disorder or other illness, which, in the view of the Principle Investigator (or their delegate) precludes informed consent and/or accurate medical evaluation.
  • 7.Patients with history of regular substance abuse
  • 8.Inability to commit or be available for follow-ups.

研究者

发起方
niversity of Queensland

相似试验